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Summary.-The normal-lymphocyte-transfer test has been advocated as a method
of assessing the immuno-competence of lymphocytes from patients with breast and
large-bowel cancer. Evidence is presented in this paper that the methodology is
subject to many uncontrollable errors, that the reaction is the result of multiple
factors, and that the size of the reaction is related to the age of the patient and not to
the extent of the malignancy.
THE intradermal injection of lympho-
cytes from one strain of guinea-pig to
another produces a reaction at the site of
the injection within 24 h (Brent & Meda-
war, 1963). Rees & Symes (1973) adapted
this normal lymphocyte transfer (NLT)
test to a human-to-mouse system. The test
consists of injecting human lymphocytes
into the skin of a mouse and measuring
the size of the reaction produced at 48 h.
These authors demonstrated that lympho-
cytes from patients with advanced malig-
nancy produced smaller reactions than
lymphocytes from a control non-neoplastic
group. They considered that NLT could be
used to assess the immuno-competence of
lymphocytes in patients with a malig-
nancy or an immunodeficiency disease.
Symes and Westwood (1974) showed that
in breast-cancer patients the size ofthe re-
action produced by NLT is related to the
stage of the disease, being larger in pa-
tients with localized disease than in
patients with disseminated disease. Miller
et al. (1975), using NLT, produced similar
results with lymphocytes from breast-
cancer patients, but in 18 patients with
large-bowel cancer the reaction wassmaller
than in a control group of patients, and
was not related to the stage ofthe disease.
Symes (1974) in a review article on Tu-
mour Immunology, cited NLT as a test
suitable for assessing immunocompetence.
The purpose of this paper is to:
(1) study the technical problems of the
NLT test;
(2) evaluate further the NLT test in
patients with a gastro-intestinal
malignancy and a group of control
non-neoplastic patients;
(3) examine the histological nature of
the reaction.
MATERIALS AND METHODS
Lymphocyte separation.-Twenty ml of
venous blood was taken from each patient
into a heparinized syringe. Four ml of blood
was layered on to 3 ml ofFicoll-Paque, a mix-
ture of Ficoll and Diatrizoate Sodium (Phar-
macia Fine Chemicals) in glass tubes. The
tubes were centrifuged at 400 g for 40 min.
The cells were then harvested and washed x 3
with medium TC-199 before counting them in
a Coulter Counter (ZF). This type oflympho-
cyte separation is similar to the method used
by Rees & Symes (1973) but it should be
noted that this method produces a mixture
of cells, mainly lymphocytes and monocytes
(>90%) but also a small proportion ofgranu-
locytes and red blood cells (<10%). In each
test 107 lymphocytes were suspended in 01
ml TC-199 for injection.
Mouse studies.-Tenx106 lymphocytes in
01 ml TC-199 were injected i.d. into the
shaved skin of Swiss inbred mice. The size of
the reaction (lump) was measured at 48 h
with calipers, measuring two diameters at
right angles and the result expressed as the
mean. In 9 mice, 01 ml TC-199 without lym-
phocytes was injected as a control.EVALUATION OF NLT TEST
Pathology.-Four large reactions (i.e. over
2-5 mm) were examined by a pathologist
using H & E and Methyl-green-pyronine
stains to assess the various components ofthe
reaction and to see whether lymphoblastic
transformation had occurred.
Staging of gastro-intestinal malignancy
Stage A: carcinoma limited to gut wall.
Stage B: carcinoma extendedbeyondgutwall.
Stage C: carcinoma involving lymph nodes.
Stage D: carcinoma with distant metastases.
This is a modification of Duke's method of
staging for carcinoma ofthe rectum.
RESULTS
Table I shows the findings in 13 patients
with a gastro-intestinal malignancy. The
mean size of the NLT reaction is 1-7 mm
(s.d.±1.04) and the average age is 63
years.
TABLE I.-Patients with a gastro-intestinal
malignancy
Age
Patient Disease* (years)
JK ECa 37
MG ECa 56
BH ECa 63
WB GCa 78
JS RCa 55
WF CCa 50
KS GCa 59
RL CCa 72
TK CCa 65
MT RCa 72
CS GCa 68
ED CCa 78
MD GCa 71
Controls Mean 63
(13)
Sex
M
F
M
M
M
F
F
M
M
F
M
M
M
9M
4F
NLT
Stage (mm)
D 3-7
B 1-9
C 1-4
B 1-6
C 1-7
D 2-9
D 2-0
B 1-5
B 0
B 0-8
C 0
D 1-7
C 3-1
Mean 1 7
s.d. 1-04
* GCa=Gastric carcinoma; ECa =Oesophageal
carcinoma; RCa--Rectal carcinoma; CCa=Colon
carcinoma.
TABLE II.-Benign control group
Patient
KR
MQ
HB
MK
CD
JH
WH
MC
DM
JK
MN
MG
HM
JD
JH
TC
Total= 16
Disease*
H
PU
GB
UC
DD
DM
H
PU
GB
H
PU
OA
PU
PU
H
PU
Age
(years)
39
63
52
50
72
65
56
64
54
65
57
66
60
70
59
52
Sex
M
M
F
F
M
F
M
M
F
M
F
M
F
M
M
M
NLT
(mm)
3-2
0
3-3
0
2-8
0
3 0
1-3
2-7
2-1
2-7
0
1-7
0
1-4
2-5
Mean 59 1OM Mean1 66
6F s.d. 1-2
* PU=Peptic Ulcer; GB=Cholelithiasis; DD =
Diverticular disease; H=Hernia; TN=Toenail;
OA=Osteoarthrosis; UC=Ulcerative Colitis; DM=
Diabetes Mellitus
TABLE III.-Benign group<30 years
Patient
IM
MS
LR
MF
MD
MM
MC
Total= 7
Age
Disease* (years) Sex
GB 29 F
PU 25 M
PU 25 M
TN 16 M
H 22 M
TN 24 F
TN 18 F
Mean 23 4M
3F
* See footnote to Table II.
NLT
(mm)
3 -2
3 -6
1*5
2-7
2 -2
2 -7
3 -5
Mean 2 * 7
s.d. 0-63
TABLE IV. -Malignant groutp breakdown
Stage B
Stage C
Stage D
< 60 years
>60 years
Age Reaction
No. (years) size (mm)
5 69 1-16
4 64 1 5
4 56 2-5
5 51 2-4
8 71 1-25
Table II shows the findings in 16 control
patients with a benign condition. Themean
size of the NLT reaction is 1-66 mm±1l2,
and the average age is 59 years. The age
and sex distribution between the 2 groups
is similar. There is no significant difference
in the size of the reaction between the 2
groups (P>0 05).
Table III shows the findings in 7 control
patients under 30 years of age with a be-
nign condition. The mean size of the NLT
reaction is 2-7 mm+063, and the average
age is 23 years.
Table IV shows a breakdown of the
malignant group into stages and ages. The
size ofthe reaction is largestinthe patients
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with more extensive disease, which is sur-
prising, but the numbers are too small for
any conclusion.
The only definite pattern to emerge
from the results is that the size of the
reaction is inversely proportional to the
age ofthe patient. Ifall groups ofpatients
are considered, the mean size of the reac-
tion in patients under 60 years ofage-2-5
mm±0 87 and in patients over 60 years of
age-1.1 mm±0 99. This difference is
highly significant (P>0.001).
From 9 control injections of TC-199
alone, there was one reaction size (2.2
mm).
Pathology results
All the specimens examined contained
fresh polymorphonuclear leucocytes which
may have come from the mouse. In 3 of
the specimens the predominant cell was
the lymphocyte, some ofwhich the Patho-
logist considered had undergone lympho-
blastic transformation. There was also a
considerable amount of debris present in
the reaction. However, in the 4th specimen
the main component ofthe reaction was an
acute inflammatory response on the part
of the mouse, with large numbers of poly-
morphs, oedema andincreased vascularity.
Also, in 3 ofthespecimensthelymphocytes
had ruptured through the dermis into the
subcutaneous tissues of the mouse, thus
dispersing the lymphocytes. It appeared
as though the volume (0.1 ml) was too
great to be accommodated within the
dermis.
Technical problems of the NLT test
(1) Leakage ofTC-199 and lymphocytes
along the injection track occurred in
about 50% of tests, making the
injection of the exact numbers of
lymphocytes inaccurate.
(2) As noted earlier, the suspended cells
are a mixture of lymphocytes,
granulocytes and red blood cells so
that the reaction may be due to any
one or a combination of these cells.
(3) The reaction in the mouse is 3 di-
mensional, but it can only be
measured in 2 dimensions.
(4) Differences in the size ofthe reaction
are in the 041 mm range, but as the
edge is poorlydefinedexactmeasure-
ment with calipers is not possible.
(5) Some reactions are linear, along the
injection track, rather than circular,
making measurement difficult (e.g.
3.5 x 0-22 mm in one specimen).
(6) The injection is meant to be intra-
dermalbut in 3 specimensexamined,
though it started i.d., the fluid
ruptured through into the sub-
cutaneous tissues.
DISCUSSION
The adapted NLT test is an interesting
idea, in that live lymphocytes are injected
into the skin of a mouse, encounter mouse
antigen for the first time, and react against
it, presumably undergoing lymphoblastic
transformation. The resulting reaction can
be seen as a lump and measured. But as
shown in the first 3 Tables the size of the
reaction is extremely variable, with a wide
standard deviation in all groups, and 5
controls giving no reaction at all. These
results are similar to other workers, who
noted no reaction in 5/32 injections (Rees
& Symes, 1973) and no reaction in 6/19
injections (Milleret al., 1975). Moreover, by
the very nature ofthe test there are many
variables i.e. is the reaction mainly a graft-
versus-host response (GVH) or a host-
versus-graft response (HVG)? Is the reac-
tion simply due to the presence ofthe lym-
phocytes and debris, or to TC-199, as oc-
curred in one control? Rees & Symes (1973)
using immunodepressed mice concluded
that the reaction is a mixture of both
GVH and HVG, with the former pre-
dominating. But it should be noted that in
one specimen the main component of the
reaction was polymorphs derived from the
mouse, and in the other 3 specimens fresh
polymorphs were also found. Also, one
reaction of 2-2 mm followed the injection
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of TC-199 alone. It would appear that the
reaction is a variable mixture of human,
mouse and TC-199 components. Compar-
ing the results in Tables II, III and IV one
can conclude that the size of the reaction
decreases as the age of the patient in-
creases, and that it is not related to the
extent of a malignant disease affecting the
gastro-intestinal tract. If the NLT test
actually measures immunocompetence,
this finding of decreasing immunocompe-
tence with age concurs with the view of
Burnet (1970). But Bone & Camplejohn
(1973) using DNCB, and Thomas & Fox
(1973) using the heterophile antibody
activity, found that immunocompetence
decreased as the extent of a gastro-
intestinal malignancy increased. This is at
variance with the findings using the NLT
test, and, combined with the technical
problems and the biological variables,
would suggest that the NLT is not a suit-
able test for assessing the immunocompe-
tence of human lymphocytes.
The author wishes to express his thanks to Dr
C. Doyle, Pathologist, and Mr N. Martin, Depart-
ment of Haematology, St. Finbarr's Hospital, Cork,
for examining the specimens and counting the
lymphocytes.
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